Park Medi World Ltd

Net profit of Park Medi World rose 11.38% to Rs 50.78 crore in the quarter ended December 2025 as against Rs 45.59 crore during the previous quarter ended December 2024. Sales rose 17.76% to Rs 409.97 crore in the quarter ended December 2025 as against Rs 348.13 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales409.97348.13 18 OPM %24.2523.78 - PBDT93.5781.83 14 PBT78.2766.81 17 NP50.7845.59 11 Powered by Capital Market - Live

Park Medi World will hold a meeting of the Board of Directors of the Company on 28 January 2026.Powered by Capital Market - Live

The board of Park Medi World at its meeting held on 05 January 2026 has approved the acquisition of whole of existing shareholding of Krishna Super-speciality Hospital which owns and operates Mahip Hospitals for a consideration of Rs 40 crore. Strategically positioned in the heart of Bathinda, Krishna Super-speciality Hospital serves as a vital healthcare hub for both urban and rural districts, offering a centralized location for multiple super-specialties. Park Medi World has been managing operations of Krishna Super-speciality Hospital since July 2025, and has now acquired 100% shareholding from the current promoters. With the addition of this hospital, Park Group increases its hospital capacity and strengthens its infrastructure, supporting its plan to reach a total of 5,260 beds by March 2028.Powered by Capital Market - Live

The board of Park Medi World at its meeting held on 19 December 2025 has approved the acquisition of 100% stake in KP Institute of Medical Sciences (KPIMS), Agra, Uttar Pradesh, in an all-cash transaction amounting Rs 245 crore. Since its launch in 2023, KPIMS has become a prominent multi-specialty provider for Agra and neighbouring areas being one of the biggest healthcare facilities in the region. Upon consummation of the acquisition, KPIMS will be a 360 beded multi super speciality hospital. Its NABH accreditation, comprehensive super-specialty services, and inclusion in major insurance and government schemes, position KPIMS strongly for sustained market growth. Powered by Capital Market - Live

This acquisition, one of the biggest healthcare facilities in the region having total capacity of 360 beds, aligns perfectly with our cluster-based growth strategy, which maximizes operational efficiencies and achieves economies of scale by locating our hospitals in close proximity. Furthermore, it significantly reinforces the Park Group's goal of strengthening our presence in key urban centres across North India. Since its launch in 2023, KPIMS has become a prominent multi-specialty provider for Agra and neighbouring areas being one of the biggest healthcare facilities in the region. Dr. Ankit Gupta, managing director, Park Medi World, said: 'By welcoming the KP Institute of Medical Sciences (KPIMS), we take a major step in expanding our presence in North India. This integration will significantly strengthen our regional presence and is anticipated to yield strong operational and financial results. Agra is a high-potential city with a clear need for dependable, high-quality medical services; thus, we are focused on enhancing KPIMS's capabilities to provide the community with advanced, modern care. The facility's excellent location makes it a critical hub for delivering consistent, patient-focused healthcare across the region, and we remain dedicated to exploring opportunities to further our growth in the area.' Park Group is North India's 2nd largest Hospital Chain, currently operating 14 hospitals with a combined capacity of 3,250 beds. In addition to this proposed facility in Agra, Park Group is in process of integrating additional six hospitals which are under various stages of execution and it will add 1,650 beds. This expansion will take Park Group's total bed capacity to 5,260 beds by March 2028. The firm reported a consolidated net profit of Rs 139.14 crore and an income from operations of Rs 808.66 crore for the nine months ended on 31 June 2025. The scrip shed 0.46% to currently trade at Rs 154 on the BSE. Powered by Capital Market - Live

The stock debuted at Rs 155.60, marking a discount of 3.95% to the issue price. So far, the stock has hit a high of 161.75 and a low of 155.60. On the BSE, over 9.79 lakh shares of the company were traded in the counter so far. The initial public offer of Park Medi World was subscribed 8.10 times. The issue opened for bidding on 10 December 2025 and it closed on 12 December 2025. The price band of the IPO is fixed between Rs 154 and 162 per share. The IPO comprised a fresh issue of equity shares worth up to Rs 770 crore and an offer for sale aggregating up to Rs 150 crore by existing shareholder Dr. Ajit Gupta. The objectives of the fresh issue include Rs 380 crore for the repayment/prepayment of outstanding borrowings, Rs 60.5 crore for funding capital expenditure towards the development of a new hospital by the subsidiary Park Medicity (NCR), Rs 27.45 crore for the purchase of medical equipment by the company and its subsidiaries, Blue Heavens and Ratangiri, and the remaining amount for inorganic acquisitions and general corporate purposes. The promoters, Dr. Ajit Gupta and Dr. Ankit Gupta, and the promoter group hold an aggregate of 36,73,07,766 equity shares, aggregating 95.55% of the pre-offer issued and paid-up equity share capital. Their post-IPO shareholding is expected to be around 82.89%. Park Medi World is a leading private hospital chain in North India, with 3,250 beds (the largest in Haryana) across 14 NABH-accredited multi-super specialty hospitals. The company offers 30+ specialties, including internal medicine, neurology, urology, gastroenterology, orthopedics, and oncology, supported by 1,014 doctors and 2,142 nurses. It has expanded through acquisitions and is building new hospitals in Ambala, Panchkula, Rohtak, Gorakhpur, and Kanpur, aiming to increase total bed capacity to 4,900 by FY28. Revenue is led by internal medicine (29.65%) and supported mainly by government schemes (83.38%). Bed occupancy stands at 68.14%, with inpatient and outpatient volumes of 46,551 and 3,92,049 respectively. Ahead of the IPO, Park Medi World, on 9 December 2025, raised Rs 275.99 crore from anchor investors. The board allotted 1.70 crore shares at Rs 162 each to 23 anchor investors. The firm reported a consolidated net profit of Rs 139.14 crore and an income from operations of Rs 808.66 crore for the nine months ended on 31 June 2025.Powered by Capital Market - Live

The equity shares of Park Medi World (Scrip Code: 544645) are listed effective 17 December 2025 and admitted to dealings on the Exchange in the list of ''B'' Group Securities. At 09:13 IST, the pre-open indicative price of the stock was at a discount of 4.32% to the issue price of 162.Powered by Capital Market - Live